Amit Kumar Chaudhary

University/Organization: University of Nebraska Medical Center

Country: United States


Dr. Amit Kumar Chaudhary is an emerging biologist who obtained a doctorate in biochemistry from the department of life science and biochemical engineering, Sun Moon University, Republic of Korea under the supervision of Professor Jae Kyung Sohng. He is an expert in metabolic engineering of microbial systems using synthetic biological approaches for production of platform chemicals and testing their biological activities. During his short period as a postdoctoral researcher under the supervision of Professor EunYeol Lee at Kyung Hee University, Republic of Korea, he studied Methanotrophs that can metabolize methane as their only source of carbon and energy. His research journey started in 2009 with prime focus on multidisciplinary approaches to engineer microbial systems for combinatorial production of small therapeutics molecules. The combination of chemical biology, molecular biology and computational biology helped him to design proteins and small regulatory-RNAs expression systems for bacteria, especially E. coli and Streptomyces. To bring his expertise into the mammalian system, he joined Professor Ram I. Mahato’s research group at University of Nebraska Medical Center, USA, where, he is actively involved in designing next-generation systems for targeted delivery of small molecules, siRNAs and miRNAs for treating various cancers. In addition, he has a track record of mentoring several undergraduate and graduate students and has published numerous articles in reputed journals and he is exceptionally a flair writer and projects designer.

 Research Interest

His research interests are Biotechnology; Biochemistry; Synthetic biology; Combinatorial synthesis of natural products and its modifications using microbial platform; Metabolic engineering and co-factors channeling; Evaluating the biological activities of natural products; Designing next-generation systems for the delivery and targeting of small molecules, siRNA and miRNA for treating various cancers; Gene therapy; Molecular biology; Genetic engineering.